IGFBPL1 and breast cancer: Previously, insulin-like growth factor binding protein-1 (IGFBP-1) induction in 4-hydroxytamoxifen (4-OHT)-treated breast cancer cells was shown to mediate the efficacy of 4-OHT (15).